AnaptysBio, Inc. (ANAB)
51.34
+0.97
(+1.93%)
USD |
NASDAQ |
Jun 08, 16:00
51.34
0.00 (0.00%)
After-Hours: 16:47
AnaptysBio EPS Diluted (Quarterly) : -1.843 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.023 |
| Vanda Pharmaceuticals, Inc. | -0.8168 |
| Precision BioSciences, Inc. | -0.7486 |
| Amgen, Inc. | 3.344 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -52.88M |
| Revenue (Quarterly) | 25.56M |
| Total Expenses (Quarterly) | 78.44M |
| Enterprise Value | 1.453B |
| Gross Profit Margin (Quarterly) | 97.61% |
| Profit Margin (Quarterly) | -206.9% |
| Earnings Yield | -2.10% |
| Operating Earnings Yield | 2.70% |
| Normalized Earnings Yield | -2.104 |